DAMORA THERAPEUT Stock Price, News & Analysis
Company Description
DAMORA THERAPEUT (NASDAQ: DMRA) is a publicly traded biotechnology company in the Pharmaceutical Preparations sector. The company has a market capitalization of $1.5B, ranking #2,422 among all listed U.S. companies by market cap.
DMRA stock has gained 1.5% over the past year. Shares last traded at $25.90.
On a trailing twelve-month basis, DAMORA THERAPEUT reported net income of -$209.8M and diluted earnings per share of $-23816.00.
This page provides a comprehensive overview of DMRA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
DAMORA THERAPEUT (DMRA) stock last traded at $25.90, up 6.72% from the previous close. Over the past 12 months, the stock has gained 1.5%. At a market capitalization of $1.5B, DMRA is classified as a small-cap stock with approximately 60.3M shares outstanding.
Latest News
DAMORA THERAPEUT has 3 recent news articles, with the latest published yesterday. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include management, earnings. View all DMRA news →
SEC Filings
DAMORA THERAPEUT has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 25, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all DMRA SEC filings →
Financial Highlights
operating income reached -$210.9M, and net income was -$209.8M. Diluted earnings per share stood at $-23816.00. The company generated -$6.7M in operating cash flow. With a current ratio of 12.98, the balance sheet reflects a strong liquidity position.
Upcoming Events
IND/CTA submission expected
Proof-of-concept datasets begin
DAMORA THERAPEUT has 2 upcoming scheduled events. The next event, "IND/CTA submission expected", is scheduled for May 1, 2026 (in 30 days). Investors can track these dates to stay informed about potential catalysts that may affect the DMRA stock price.
Short Interest History
Days to Cover History
DMRA Company Profile & Sector Positioning
DAMORA THERAPEUT (DMRA) operates in the Biotechnology industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.